Feature and impact of guideline-directed medication prescriptions for heart failure with reduced ejection fraction accompanied by chronic kidney disease

Autor: Hsiu-Yu Fang, Huang-Chung Chen, Chi-Ling Hang, Cheng-I Cheng, Chien-Hao Su, Morgan Fu, Po-Jui Wu, Yen-Nan Fang, Yung-Lung Chen, Shyh-Ming Chen
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Adult
Male
medicine.medical_specialty
Adrenergic beta-Antagonists
Renal function
Angiotensin-Converting Enzyme Inhibitors
Comorbidity
urologic and male genital diseases
Drug Prescriptions
Severity of Illness Index
Angiotensin Receptor Antagonists
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
Humans
heart failure with reduced ejection fraction
Prospective Studies
Renal Insufficiency
Chronic

Aged
Mineralocorticoid Receptor Antagonists
Aged
80 and over

Heart Failure
Ejection fraction
business.industry
Cardiovascular Agents
Stroke Volume
General Medicine
Middle Aged
medicine.disease
guideline-directed medications
mortality
Thyroid disorder
female genital diseases and pregnancy complications
Treatment Outcome
Blood pressure
Case-Control Studies
Heart failure
Practice Guidelines as Topic
Propensity score matching
Cohort
Female
030211 gastroenterology & hepatology
business
chronic kidney disease
Kidney disease
Research Paper
Zdroj: International Journal of Medical Sciences
ISSN: 1449-1907
Popis: Background: With respect to total mortality and cardiovascular mortality, the feature and impact of guideline-directed medication (GDM) prescriptions for heart failure with reduced ejection fraction (HFrEF) with chronic kidney disease (CKD) are unknown. Therefore, we aimed to determine these aspects. Methods: GDM prescriptions and their impact on discharged patients with and without CKD were analyzed. To analyze differences in one-year clinical outcomes, propensity score matching was conducted on a cohort of patients with concomitant HFrEF and CKD who received more and fewer GDM prescriptions. Results: A total of 1509 patients were enrolled in Taiwan's HFrEF registry from May 2013 to October 2014, and 1275 discharged patients with complete one-year follow-up were further analyzed. Of these patients, 468 (36.7%) had moderate CKD, whereas 249 (19.5%) had advanced CKD. Patients with advanced CKD received fewer prescribed GDMs than other patients. Multivariate analysis revealed that peripheral arterial occlusive disease, thyroid disorder, advanced HF at discharge, diastolic blood pressure, digoxin use, and fewer prescribed GDMs were independent predictors of one-year total mortality. After propensity score matching, patients with fewer prescribed GDMs had higher one-year total mortality rate than those with more prescribed GDMs (P=0.036). Conclusions: CKD at discharge from HF hospitalization was associated with fewer GDM prescriptions, particularly in patients with more advanced CKD. The propensity-matched analysis indicated that more GDM prescriptions led to better clinical outcomes in HFrEF patients with CKD. Careful interpretation of changes in renal function during HF hospitalization may improve GDM prescriptions.
Databáze: OpenAIRE